Cite
MLA Citation
Thokozile R Malaba et al.. “72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study.” Lancet, vol. 9, no. 8, 2022, pp. e534–e543. http://access.bl.uk/ark:/81055/vdc_100160128484.0x000006